ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26,426 | -34.7% | 659 | -24.5% | 0.00% | -33.3% |
| Q4 2022 | $40,446 | +12.4% | 873 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $36,000 | -30.8% | 873 | 0.0% | 0.01% | -25.0% |
| Q2 2022 | $52,000 | -5.5% | 873 | +15.6% | 0.01% | +14.3% |
| Q1 2022 | $55,000 | -12.7% | 755 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $63,000 | -7.4% | 755 | 0.0% | 0.01% | -11.1% |
| Q3 2021 | $68,000 | -5.6% | 755 | 0.0% | 0.01% | -10.0% |
| Q2 2021 | $72,000 | -24.2% | 755 | -9.0% | 0.01% | -28.6% |
| Q1 2021 | $95,000 | -24.0% | 830 | -8.1% | 0.01% | -30.0% |
| Q4 2020 | $125,000 | +101.6% | 903 | +20.4% | 0.02% | +66.7% |
| Q3 2020 | $62,000 | +77.1% | 750 | +69.7% | 0.01% | +71.4% |
| Q2 2020 | $35,000 | +75.0% | 442 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $20,000 | – | 442 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |